Epsilon Eye Care: Crafting Vision with Precision Tools to Revamp Ophthalmic Surgery

Shyam Anand, CEO & Managing Director

Shyam Anand

CEO & Managing Director

Technological changes, emergence of minimally invasive surgeries and mounting awareness regarding planned eye care procedures have catalyzed a fast pace of industry-wide change faced by the global ophthalmic surgical instruments business.

As patients require accuracy and safety, and surgeons want the tools that provide both reliability and innovation, manufacturers need to produce the best and innovative solutions that can assist surgical performance. In this changing scenario, India has become a key player, home to companies that combine engineering skill with medical insight to serve both domestic and global markets.

Among these great players is Epsilon Eye Care which has established a niche in the market of ophthalmic instruments. Making a smooth transition from a modest beginning into a globally recognized brand, it does not only devise the instruments but enables surgeons to discover and restore sight with unmatched accuracy and confidence.

As a company that operates based on innovation, collaboration with surgeons, and commitment to quality, it has earned the reputation of a precision-driven and trustworthy player in the complex realm of eye care.

The company was established back in 1997 purely as a trading firm. But, due to the far-sighted vision of Shyam Anand, Founder of Epsilon Eye Care, who brings decades of experience in the surgical instrument manufacturing, it has become a highly specialized manufacturer of surgical instruments, today. Furthermore, the early days were humble, with just five workers and a small inventory of 100 instruments. Titanium, then unavailable locally, was imported to meet the niche demand.

With the technological advancements and availability of titanium in India, the company took an advantage to grow and diversify its portfolio to include fine surgical instruments. As eye health became widely known, patients started developing their surgical procedures carefully, conducting research on surgeons, procedures, and even on instruments that would be used.

This shift in patient behavior further boosted the demand for high-quality, precision instruments, a need Epsilon was uniquely positioned to fulfill.

From Surgeon’s Vision to Precision Instruments

Today, the company operates out of two factories in Gujarat, which are staffed by over 125 employees. Many of the employees have been with the company for decades, showcasing how positive the culture has been for professionals. It is not only the manufacturing ability which gives the company an edge, its focus towards craftsmanship is also central in its thinking.

Instruments are produced under high magnification. Another noteworthy aspect would be that none of these are mass-produced instruments, rather, each instrument is hand-finished, much as a piece of jewellery would be and the primary concern is precision.

The company places significant investments in human capital, regularly training and upskilling its employee base in a master-apprentice fashion, ensuring that the legacy of meticulous manufacturing continues uninterrupted.

The founder signifies, “Epsilon’s ability to transform a surgeon’s idea into a functional instrument has earned it accolades and partnerships across the world. With typical challenges experienced in the middle of a surgery, surgeons often get to innovate at their moment of need. Many of its best-known products have originated from such surgeon-led insights.

These concepts are converted to sketches, developed into prototypes, and finally, after stringent testing and reviews, they are introduced into the market. With in-house R&D and advanced equipment such as its CNC, wire-cutting and laser machines, the company is able to ensure that its products meet stringent global standards with good repeatability and minimal rejection rates.

Epsilon Eye Care's ability to transform a surgeon’s idea into a functional instrument has earned it accolades and partnerships across the world

Shyam Anand, CEO & Managing Director

Setting Standards in Quality, Compliance, & Care

The company’s innovation-first philosophy has been recognized by prestigious institutions such as the Ministry of Health, the American Academy of Ophthalmology, and various state ophthalmic societies. Besides being commercially successful, it has also contributed to humanitarian causes, most notably during a Kashmir conflict when it designed specialized instruments within 72 hours to extract glass beads and gun pellets stuck in the eyes of the victims.

Not only did this incredible contribution save an infinite number of patients from irreversible consequences of losing sight but it also gained the company widespread acclaim for its responsiveness and sense of duty. Additionally, Epsilon’s regulatory and quality systems are equally robust. I t is ISO-certified and complies with all CDSCO requirements, with manufacturing licenses in place.

“Every equipment is subjected to strict SOP and technical designs and quality checks are put in place at all points of manufacturing, starting from raw material procurement to finished product”, explains Shyam Anand, CEO & Managing Director, Epsilon Eye Care. These standards of excellence have enabled the company to become the OEM partner of choice to nearly all big multinational companies in India.

Although its international presence is supported by an established relationship with a major distributor in the US, the company has extended its presence to Asian markets and has many direct purchasers across the globe. Domestically, its reach is extensive, with 85 channel partners across India and a dedicated sales team that not only markets the instru­ments but also assists surgeons in operating theatres. These representatives collect feedback, assist with usage, and of­ten serve as the first touchpoint for new product ideas.

In addition, the company participates in medical conferences and continuous medical education (CME); ensuring its in­novations remains visible and accessible to India’s vibrant ophthalmic community.

Fueling Innovation with Global Insight & Financial Discipline

Some of the most demanded instruments include those used during cataract surgery, vitreo-retinal surgery, and in corneal surgery. Other products such as capsulorhexis forceps and bimanual systems are also very popular and it is estimated that 70-80 percent of ophthalmologists throughout India are leveraging at least two Epsilon products.

The company’s solutions have also gained traction globally, having been developed in close collaboration with leading surgeons from both India and abroad, many of whom have contributed significantly to the advancement of its product portfolio.

A Journey of Excellence

The company’s journey is not only marked by technical achievements but also by financial prudence. Remarkably, it is entirely debt-free, having never taken a bank loan. It has self-financed all growth using the profits of the business. This financial stability signifies its quality discipline and sustainable plan of growth.

For its founder, ophthalmology has been a lifelong passion. He has attended almost all ophthalmic conferences in India and overseas over the last forty years. He remains a thought leader in the space as he is the president of the All India Ophthalmic Manufacturers & Traders Association and is generally known as a living encyclopedia of the industry.

Engineering the Future of Sight

Going forward, Epsilon Eye Care is poised for continued evolution. Its systems are designed for longevity, and its adaptability to emerging trends ensures it remains future-ready. Just as it has transitioned smoothly from manual craftsmanship to precision automation, the company is prepared to embrace the next frontier of ophthalmic care.

Within this industry, where precision, dependability and speed may make the difference between seeing and being blind, Epsilon Eye Care has established itself as a trusted partner to surgeons worldwide. It is a company built on precision, powered by people, and guided by a purpose, which is to restore sight, one instrument at a time.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.